Curaleaf
Curaleaf 22/1 LC
Strain: Lavender Cake
A high-THC indica-dominant cultivar from Curaleaf, distributed exclusively by Motagon in the Czech Republic.
Specification
| Strain | Lavender Cake |
| THC | 23.0% |
| CBD | 0.07% |
| Type | Indica-dominant |
| Irradiation | Irradiated |
| PDK / APA code | 5567236 |
| SÚKL code | 9190000 |
| Distributor | PHARMOS |
| Current batch | 25LC005EB1Y012 |
| Expiry | 11/2026 |
Line
Distributed brand. Motagon is the exclusive Czech distributor for Curaleaf.
Irradiation
This product is irradiated. Gamma irradiation is used to meet microbiological limits. It leaves cannabinoid content largely intact and reduces terpene content. The evidence.
Prescribing
Prescribed on eRecept under SÚKL code 9190000, created as a narcotic (NL) prescription. State the route of administration, the quantity in grams, and the exact THC and CBD percentages with the product name in the note field, for example:
THC 23.0% CBD 0.07% Curaleaf 22/1 LC
Release
Released under EU-GMP in Czechia by Motagon’s Qualified Person. Batch number, certificate of analysis, expiry date and dispensing codes travel with the pack.
Other products
-
Mota® ROSE
MotaCHEESE 18/1 ROSE
A THC-dominant sativa-dominant cultivar. Commonly selected for patients with established tolerance, or where a balanced profile has not given sufficient relief.
Exodus Cheese
- THC / CBD
- 17.9% / 0.2%
- Type
- Sativa-dominant
- Irradiation
- Non-irradiated
- PDK / APA
- 5477709
-
Mota® SILVER
MotaBATHA 8/10 SILVER
A balanced THC and CBD profile. Commonly the starting point for cannabis-naive, older or anxiety-sensitive patients.
Batha Balanced
- THC / CBD
- 8.3% / 10.6%
- Type
- Sativa-dominant
- Irradiation
- Non-irradiated
- PDK / APA
- 5560041
-
Curaleaf
Curaleaf 24/1 WPT
A high-THC sativa-dominant cultivar from Curaleaf, distributed exclusively by Motagon in the Czech Republic.
Wedding Pop Triangle
- THC / CBD
- 23.8% / 0.05%
- Type
- Sativa-dominant
- Irradiation
- Irradiated
- PDK / APA
- 5567244
This page is intended for healthcare professionals. It is not advice on the treatment of an individual patient and does not replace national prescribing guidance or your own clinical judgement.